Korean J Gastroenterol.  2010 Apr;55(4):273-274. 10.4166/kjg.2010.55.4.273.

Reactivation of Inflammatory Bowel Disease in a Mouse Model of Depression. (Gastroenterology 2009;136:2280-2288)

• Kim YS

• KMID: 1792781
• DOI: http://doi.org/10.4166/kjg.2010.55.4.273

Abstract

No abstract available.

Reference

1. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007; 132:507–515.

2. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD Cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008; 103:1989–1997.

3. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008; 118:2209–2218.

4. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology. 2009; 136:2280–2288.

5. Rook GA, Lowry CA. The hygiene hypothesis and psychi-atric disorders. Trends Immunol. 2008; 29:150–158.

6. Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short-and long term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005; 22:101–110.

7. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006; 55(suppl 1):S36–S58.